Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy
about
Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy
description
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Increased derived neutrophil-t ...... with neoadjuvant chemotherapy
@en
Increased derived neutrophil-t ...... with neoadjuvant chemotherapy
@nl
type
label
Increased derived neutrophil-t ...... with neoadjuvant chemotherapy
@en
Increased derived neutrophil-t ...... with neoadjuvant chemotherapy
@nl
prefLabel
Increased derived neutrophil-t ...... with neoadjuvant chemotherapy
@en
Increased derived neutrophil-t ...... with neoadjuvant chemotherapy
@nl
P2093
P2860
P356
P1476
Increased derived neutrophil-t ...... with neoadjuvant chemotherapy
@en
P2093
P2860
P304
P356
10.2147/CMAR.S174537
P407
P577
2018-01-01T00:00:00Z